Reach Us +1-947-333-4405
Candidaemia in Immune-Compromised Hosts: Incidence and Drugs Susceptibility | OMICS International | Abstract
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Candidaemia in Immune-Compromised Hosts: Incidence and Drugs Susceptibility

Maria T. Mascellino*, Giammarco Raponi, Alessandra Oliva, Claudio M. Mastroianni and Vincenzo Vullo

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy

*Corresponding Author:
Maria Teresa Mascellino
Department of Public Health and Infectious Diseases
Sapienza University of Rome, Italy
Tel: +39- 3281685935
Fax: +39- 0649972628
E-mail: [email protected]

Received date: September 21, 2012; Accepted date: October 17, 2012; Published date: October 20, 2012

Citation: Mascellino MT, Raponi G, Oliva A, Mastroianni CM, Vullo V (2012) Candidaemia in Immune-Compromised Hosts: Incidence and Drugs Susceptibility. J Clin Exp Pathol 2:131. doi:10.4172/2161-0681.1000131

Copyright: © 2012 Mascellino MT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


We analyzed the different Candidae species isolated from bloodstream infections and the related antifungal susceptibility pattern over a five-year period (2007-2011) at Policlinico Umberto I of Rome (Italy).
The overall incidence of candidaemia during this range of time accounted for 6.4% with a marked increase from 2007 to 2011 (from 3.83% to 9%). The species isolated were the following: C. albicans (42%) and non-albicans (58%). In the period 2007-2009, C.krusei was the most frequent species detected among non-albicans species (29.4%), followed by C.glabrata (20%), whereas during 2010-2011 we found a shift versus C. parapsilosis increasing from 4.6% to 33%.
C.albicans showed a good susceptibility to the most antifungal agents. C. krusei exhibited a raising resistance to flucytosin and fluconazole. As for fluconazole, it shows an intrinsic resistance. In C. glabrata we observed increased resistance especially to fluconazole for which this species shows a Susceptibility Dose-Dependent (SDD). C.tropicalis had only a resistance to fluconazole (MIC 90%=16 mcg/ml) In vitro activity of the echinocandins resulted to be very strong for all Candidae species. These drugs have a fungicidal activity and their use is recommended in the most severe diseases.
Our study confirms the high incidence of candidaemia in the setting of critically ill patients. A strong association of Candidae infection with the presence of Central Venous Catheter (CVC) has been markedly noticed especially in the years 2009 and 2011 due to a greater use of CVC in our patients. The overall rate of resistance increased over the study period in all Candidae strains.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version